15 Wevers-De Boer K, Visser K, Heimans L, et al. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)[J]. Ann Rheum Dis, 2012, 71(9): 1472-1477.
17 Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data[J]. Ann Rheum Dis, 2006, 65(3): 285-293.
[5]
18 García-Gómez C, Nolla JM, Valverde J, et al. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy[J]. Eur J Clin Invest, 2008, 38(9): 686-692.
[6]
1 Gorter SL, Bijlsma JW, Cutolo M, et al. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis[J]. Ann Rheum Dis, 2010, 69(6): 1010-1014.
[7]
2 Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs[J]. Ann Rheum Dis, 2010, 69(6): 964-975.
[8]
3 Smolen JS, Aletaba D, Keystone E. Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction [J]. Arthritis Rheum, 2005, 52(10): 2975-2983.
[9]
4 Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial[J]. Arthritis Rheum, 2005, 52(11): 3381-3390.
7 Van Dongen H, Van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial[J]. Arthritis Rheum, 2007, 56(5): 1424-1432.
10 Huisman AM, Van Everdingen AA, Wenting MJ, et al. Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis[J]. Ann N Y Acad Sci, 2002, 966: 64-67.
[16]
11 Malysheva O, Baerwald CG. Low-dose corticosteroids and disease-modifying drugs in patients with rheumatoid arthritis[J]. Clin Exp Rheumatol, 2011, 29(5, 68): S113-S115.
